Genomics of Acute Myeloid Leukemia
- 1 November 2011
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in The Cancer Journal
- Vol. 17 (6), 487-491
- https://doi.org/10.1097/ppo.0b013e31823c5652
Abstract
The acute myeloid leukemia (AML) genome has been the subject of intensive research over the past 4 decades. New technologies, enabling characterization of the AML genome at increased resolution, have revealed deeper layers of complexity that have provided insights into the biological basis of this disease, nominated targets for therapy, and identified biomarkers predictive of response to therapy or long-term prognosis. Still, our understanding of AML genomics is incomplete. Recent publications have demonstrated that whole genome sequencing of primary AML samples is feasible and can detect novel, clinically relevant mutations. New insights are emerging from this work, including the clonal heterogeneity of this disease and clonal evolution that occurs over time. Some of the novel mutations are highly recurrent (>20% of patients), but there appears to be a continuum of mutation frequency down to rare (<5%) or even singleton mutations that may be relevant for the biology of this disease. Large cohorts of well-annotated samples are needed to establish mutation frequencies, implicate biological pathways, and demonstrate genotype–phenotype correlations. Although many technical and logistical challenges must be overcome, the capacity of whole genome sequencing to detect all classes of inherited and acquired genetic abnormalities makes it an attractive candidate for development as a clinical diagnostic test.Keywords
This publication has 29 references indexed in Scilit:
- Use of Whole-Genome Sequencing to Diagnose a Cryptic Fusion OncogeneJama-Journal Of The American Medical Association, 2011
- Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia GenomeNew England Journal of Medicine, 2009
- Chromosomes in Leukemia and Beyond: From Irrelevant to Central PlayersAnnual Review of Genomics and Human Genetics, 2009
- Acquired copy number alterations in adult acute myeloid leukemia genomesProceedings of the National Academy of Sciences of the United States of America, 2009
- IDH1andIDH2Mutations in GliomasNew England Journal of Medicine, 2009
- DNA sequencing of a cytogenetically normal acute myeloid leukaemia genomeNature, 2008
- Somatic mutations affect key pathways in lung adenocarcinomaNature, 2008
- Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemiaNature, 2007
- A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesisNature Medicine, 2006
- Cytoplasmic Nucleophosmin in Acute Myelogenous Leukemia with a Normal KaryotypeNew England Journal of Medicine, 2005